When was Elucid founded?

Elucid was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is Elucid located?

Elucid is headquartered in Boston, United States.

How many employees does Elucid have?

As of Mar 31, 2026, the latest employee count at Elucid is 143.

Is Elucid a funded company?

Elucid is a funded company, having raised a total of $152M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 28, 2013.

When was the latest funding round of Elucid?

Elucid's latest funding was a $***** Series C round on Oct 10, 2025, with participation from 0 investor.

Where does Elucid rank among its competitors?

Elucid ranks 3rd amongst 31 active competitors, of which 13 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Vista, which secured $29.5M in Jan, 2026.

Who are the top competitors of Elucid?

Elucid's top competitors include Ultromics, Vista and UltraSight. Among them, Vista secured the most recent funding round in January, 2026.

Elucid - 2026 Company Profile, Team, Funding & Competitors

Elucid is a series C company based in Boston (United States), founded in 2013 by Andrew J Buckler and James Hamilton. It operates as an AI-based arterial analysis software for providers. Elucid has raised $152M in funding. The company has 31 active competitors, including 13 that are funded. Its top competitors include companies like Ultromics, Vista and UltraSight.

Company Details

AI-based arterial analysis software for providers. The company has developed software that assists with different clinical diagnostic analyses. It has features for clinical research, personalized patient care, stroke prediction, and more.

Website: elucid.com
Social
Email ID: *****@elucidbio.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

Boston, United States

Stage

Series C

Total Funding

$152M in 7 rounds

Latest Funding Round

Series C, Oct 10, 2025, $*****

Investors

Lifeblood & 10 more

Ranked

3^rd among 31 active competitors

Employee Count

143 as on Mar 31, 2026

Similar Companies

Ultromics & 32 more

View Elucid's full profile

Elucid is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Elucid Bioimaging Inc. CIN: 46-3466297 , United States, Active	Aug 19, 2013	$1 - $1M (As on Aug 28, 2013)	28 (As on Dec 31, 2021)	-

Elucid has raised a total funding of $152M over 7 rounds. Its first funding round was on Aug 28, 2013. Elucid has 11 institutional investors.

Here is the list of recent funding rounds of Elucid:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 10, 2025	3359017	Series C	6137489	5796312	9682947	2105500
Oct 20, 2023	7225051	Series C	1429739	7128097	4014672	Elevage Medical Technologies
Jun 22, 2022	2557853	Series B	7191296	8650735	7086860	MedTex Ventures & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Elucid's funding rounds and investors

The founders of Elucid are Andrew J Buckler and James Hamilton.

Here are the details of Elucid's key team members:

Andrew J Buckler: Co-Founder & President of Elucid and founder of 1 other company.
Contact Info: 1 email address
James Hamilton: Co-Founder of Elucid.

View details of Elucid's Founder profiles and Board Members

Elucid's employee count trend

Elucid has 143 employees as of Mar 26. Here is Elucid's employee count trend over the years:

Uncover Elucid's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Elucid include Ultromics, Vista and UltraSight. Here is the list of Top 10 competitors of Elucid, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ultromics 2017, Oxford (United Kingdom), Series C	Developer of artificial intelligence software for analyzing cardiac ultrasound images	$116M	Oxford Science Enterprises, Mayo Clinic Business Accelerator ... & 23 others	63/100
2nd	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Khosla Ventures, Open Field Capital & 12 others	63/100
3rd	Elucid 2013, Boston (United States), Series C	AI-based arterial analysis software for providers	$152M	Lifeblood, IAG Capital Partners & 9 others	59/100
4th	UltraSight 2018, Rehovot (Israel), Series B	AI-based platform providing ultrasound diagnosis for cardiac disorders	$14.1M	Yozma Group Korea, Weizmann Institute of Science ... & 4 others	58/100
5th	Circle Cardiovascular Imaging 2008, Calgary (Canada), Series B	Provider of a software for the evaluation of cardiac MR and CT images	$19.9M	Kayne Anderson Capital Advisors, Thoma Bravo ... & 7 others	56/100
6th	BrightHeart 2020, Paris (France), Series A	Provider of ultrasound screening services	$12.9M	Odyssee Venture, GO CAPITAL & 4 others	52/100
7th	Us2.ai 2017, Singapore (Singapore), Series A	AI-powered tool for the detection of heart risk	$19.1M	EDBI, IHH Healthcare Berhad & 15 others	50/100
8th	Medipixel Technologies 2017, Seoul (South Korea), Series B	Provider of AI-based robot for diagnosis and surgery for cardiac diseases	$19.5M	Mirae Asset, Partners Investment & 10 others	48/100
9th	DESKi 2016, Bordeaux (France), Seed	Provider of AI-based medical image analysis platform	$6M	Racine², BNP Paribas Developpement & 4 others	39/100
10th	Dyad Medical 2016, Boston (United States), Seed	AI-based platform for medical image analysis	$3.5M	The Unofficial Syndicate, Social Starts & 3 others	38/100